RecruitingNot applicableNCT04250493
Insulin Resistance in Multiple System Atrophy
Studying Rare parkinsonian syndrome due to neurodegenerative disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Bordeaux
- Intervention
- Homeostasis Model Assessment of insulin resistance (HOMA)(biological)
- Enrollment
- 124 enrolled
- Eligibility
- 30 years · All sexes
- Timeline
- 2020 – 2027
Study locations (1)
- CHU de Bordeaux, Bordeaux, France
Collaborators
University of Bordeaux · Labex Brain · Centre National de la Recherche Scientifique, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04250493 on ClinicalTrials.govOther trials for Rare parkinsonian syndrome due to neurodegenerative disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06785948tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver BurdenAssociation de Recherche Bibliographique pour les Neurosciences
- RECRUITINGNANCT06072105Medical Decision Making in Multiple System AtrophyMedical University Innsbruck
- ACTIVE NOT RECRUITINGNCT05453058Observational Study in Multiple System AtrophyH. Lundbeck A/S
- RECRUITINGNCT02194816Modifiable Variables in Parkinsonism (MVP)Bastyr University
See all trials for Rare parkinsonian syndrome due to neurodegenerative disease →